Share

See Also

Home / ACCCBuzz Blog / Full Story (testing)

ACCC Asks Senate Leaders to Include Clinical Trial Diversity Provisions in PDUFA Reauthorization

Jun 8, 2022, 09:54 AM by User Not Found

In a letter to Senate Health, Education, Labor & Pensions (HELP) Committee leadership, ACCC and 71 other patient advocacy organizations urge the Committee to include House-passed clinical trials diversity provisions in the Senate version of the Prescription Drug User Fee Act (PDUFA) reauthorization package.
Read the Letter

«« Previous
ACCC Submits Comments to FDA on Draft Guidance to Increase Diversity in Clinical Trials
Next »»
ACCC Urges Congress to Pass Legislation Improving Clinical Trial Diversity

Categories